[go: up one dir, main page]

WO2013177253A3 - Inhibiteurs de l'acide gras synthase - Google Patents

Inhibiteurs de l'acide gras synthase Download PDF

Info

Publication number
WO2013177253A3
WO2013177253A3 PCT/US2013/042173 US2013042173W WO2013177253A3 WO 2013177253 A3 WO2013177253 A3 WO 2013177253A3 US 2013042173 W US2013042173 W US 2013042173W WO 2013177253 A3 WO2013177253 A3 WO 2013177253A3
Authority
WO
WIPO (PCT)
Prior art keywords
fatty acid
acid synthase
synthase inhibitors
inhibitors
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2013/042173
Other languages
English (en)
Other versions
WO2013177253A2 (fr
Inventor
Nicholas David ADAMS
Terence John Kiesow
Kenneth Wiggall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
GlaxoSmithKline LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline LLC filed Critical GlaxoSmithKline LLC
Publication of WO2013177253A2 publication Critical patent/WO2013177253A2/fr
Anticipated expiration legal-status Critical
Publication of WO2013177253A3 publication Critical patent/WO2013177253A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne des composés de Formule (I), où R1, R2, R3, R4, R5, R6, R7, R8, R9, Y, m, et n sont définis présentement, et des procédés d'utilisation de ceux-ci.
PCT/US2013/042173 2012-05-22 2013-05-22 Inhibiteurs de l'acide gras synthase Ceased WO2013177253A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261650224P 2012-05-22 2012-05-22
US61/650,224 2012-05-22

Publications (2)

Publication Number Publication Date
WO2013177253A2 WO2013177253A2 (fr) 2013-11-28
WO2013177253A3 true WO2013177253A3 (fr) 2015-06-18

Family

ID=49624505

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2013/042173 Ceased WO2013177253A2 (fr) 2012-05-22 2013-05-22 Inhibiteurs de l'acide gras synthase

Country Status (1)

Country Link
WO (1) WO2013177253A2 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070149512A1 (en) * 2005-12-09 2007-06-28 Solvay Pharmaceuticals Gmbh N-Sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions
US20090281097A1 (en) * 2006-04-14 2009-11-12 Takeda Pharmaceutical Company Limited Nitrogen-containing heterocyclic compound
US20100160337A1 (en) * 2008-12-18 2010-06-24 Matthews Jay M Sulfamides as trpm8 modulators
WO2012064642A1 (fr) * 2010-11-08 2012-05-18 Glaxosmithkline Llc Inhibiteurs d'acide gras synthase

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070149512A1 (en) * 2005-12-09 2007-06-28 Solvay Pharmaceuticals Gmbh N-Sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions
US20090281097A1 (en) * 2006-04-14 2009-11-12 Takeda Pharmaceutical Company Limited Nitrogen-containing heterocyclic compound
US20100160337A1 (en) * 2008-12-18 2010-06-24 Matthews Jay M Sulfamides as trpm8 modulators
WO2012064642A1 (fr) * 2010-11-08 2012-05-18 Glaxosmithkline Llc Inhibiteurs d'acide gras synthase

Also Published As

Publication number Publication date
WO2013177253A2 (fr) 2013-11-28

Similar Documents

Publication Publication Date Title
WO2012122011A3 (fr) Amino-quinoléines en tant qu'inhibiteurs de kinase
WO2011088027A8 (fr) Composés et procédés
WO2014011911A3 (fr) Inhibiteurs d'irak et leurs utilisations
WO2014011906A3 (fr) Inhibiteurs d'irak et leurs utilisations
WO2014052563A3 (fr) Nouveaux composés inhibiteurs de erk
WO2011143772A9 (fr) Inhibiteurs de la réplication du vih
WO2012158843A3 (fr) Inhibiteurs de kinase
HK1210696A1 (en) Irak inhibitors and uses thereof
WO2014100764A3 (fr) Procédés d'inhibition de prmt5
WO2011153157A3 (fr) Inhibiteurs benzoquinolone de vmat2
EP2566477A4 (fr) Amino-quinoléines en tant qu'inhibiteurs de kinase
WO2013003298A3 (fr) Inhibiteurs de pde10
WO2014124230A3 (fr) Inhibiteurs d'erk et leurs utilisations
WO2014014835A8 (fr) Formes cristallines d'un inhibiteur de la prolyl hydroxylase
PH12014502169A1 (en) N-cyclylamides as nematicides
SG11201503646TA (en) Esterification of 2,5-furan-dicarboxylic acid
IN2014DN09346A (fr)
CA2873723A1 (fr) Inhibiteurs pyrrolopyrimidone et pyrrolopyridone de la tankyrase
WO2012065019A3 (fr) Inhibiteurs pyridopyrimidinone de p13k alpha
EP3087184A4 (fr) Procédé et composition pour l'inhibition spécifique de la glycolate oxydase (hao1) par un arn bicaténaire
WO2012101011A3 (fr) Nouveaux dérivés d'arylbenzocycloalkylamides
EA201590552A1 (ru) Аминохинолины в качестве ингибиторов киназы
EP2908636A4 (fr) Compositions comprenant du peroxyacide
WO2017015433A3 (fr) Composé ciblant le facteur d'activation d'il-23 et des lymphocytes b (baff) et utilisations associées
WO2015077657A3 (fr) Inhibiteurs de stat3 et leurs utilisations

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13793844

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13793844

Country of ref document: EP

Kind code of ref document: A2